Aurinia Pharmaceuticals Earnings
NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 16.65 0.00%
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$0.21
Aurinia Pharmaceuticals earnings summary
Aurinia Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $0.21. In its most recent report on Aug 6, 2026 (Q2 2026), AUPH posted EPS of $0.28. Revenue for the quarter was $83.2 million.
Quarterly EPS is up 75.0% from the same quarter a year earlier. Across the last 16 reports, AUPH shares moved an average of 3.5% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
AUPH earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $0.28 | — | -2.4% |
| May 7, 2026 | — | $0.25 | — | +0.3% |
| Feb 26, 2026 | — | $1.53 | — | +1.1% |
| Nov 4, 2025 | — | $0.23 | — | +5.1% |
| Jul 31, 2025 | — | $0.16 | — | +8.4% |
| May 12, 2025 | — | $0.16 | — | -1.3% |
| Feb 27, 2025 | — | $0.01 | — | +2.5% |
| Nov 7, 2024 | — | $0.10 | — | -2.4% |
| Aug 1, 2024 | — | $0.01 | — | -1.8% |
| May 2, 2024 | — | $-0.07 | — | -1.6% |
| Jan 5, 2024 | — | $-0.19 | — | -7.9% |
| Nov 2, 2023 | — | $-0.09 | — | -6.0% |
| Aug 3, 2023 | — | $-0.08 | — | -3.3% |
| May 4, 2023 | — | $-0.18 | — | -7.1% |
| Feb 28, 2023 | — | $-0.18 | — | -2.2% |
| Nov 3, 2022 | — | $-0.06 | — | +2.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.